About us

We want to challenge and improve today’s standardized treatments with the help of our AI-Immunology™ platform. In the field of oncology, we create truly personalized therapies where one size fits one, and only one. Within infectious diseases, we use the technology to design next-generation vaccines to address unmet medical needs.

Our purpose

Modern medicine is advancing rapidly, yet too many people still die of cancer, drug-resistant bacteria, and other infectious diseases. The demand for new, efficient drugs has never been higher and will only grow. Every day, our AI-Immunology™ platform is bringing us closer to a future where we will be able to treat a wide range of critical diseases in a targeted, patient-specific way. We see an immense market for new, efficient, and personalized drugs, as well as a substantial way to improve patients’ quality of life. This is why our purpose is: Decoding the human immune system to develop novel vaccines for cancer and infectious diseases with our AI-Immunology™ platform.

How we do it

At Evaxion, our AI-Immunology™ platform is at the heart of our work to revolutionize drug development and ultimately save the lives of patients. We bridge AI technology, bioinformatics, and drug development to bring novel immunotherapies to patients. We have used our AI to generate a broad pipeline of candidate immunotherapies that address two of the most significant unmet medical needs worldwide: cancer and infectious diseases.

Why AI?

The predictive power of our AI models comes from our ability to process and interpret vast amounts of data. These data are transformed into advanced algorithms that we believe can accurately predict cellular interactions and identify the right target to stimulate a relevant, potentially lifesaving response.

Our key facts (as of August 2025)

0

years of development

0

Initial Public Offering (IPO) on U.S. Nasdaq

0

personalized vaccine batches manufactured to date for clinical use

0%

success rate on vaccine manufacturing for all enrolled patients where a vaccine could be designed

0

AI building blocks that can be ensembled into multiple different models

0

in-house developed assets between preclinical and phase 2

0

preclinical studies

0

patent families covering multiple inventions across AI-Immunology™ and pipeline assets

Careers

As a pioneering and leading TechBio company, we seek, employ, and develop the best scientific minds and extraordinarily skilled people. At Evaxion, you will work in a fast-paced environment that cultivates a collaborative and innovative spirit. From our cutting-edge science to our company culture, we strive for excellence in everything we do. With some of the most talented bioinformaticians, scientists, and executives in the field, we are committed to making our vision for better global health a reality. Play an instrumental role in the expansion of Evaxion and explore our open positions.

Evaxion leadership team

Evaxion is comprised of an experienced leadership team and advisors with a proven track record from leading pharmaceutical companies and universities.

Evaxion board of directors

Evaxion is comprised of an experienced leadership team and advisors with a proven track record from leading pharmaceutical companies and universities.